Spotlight
Clinical Role
Clinical
Supplement Spotlight
CE
Subscribe
Publication
Article
Pharmacy Practice in Focus: Health Systems
January 2019Volume8 Issue 1
Progress in Treating Advanced Melanoma: Pharmacists
Author(s):
In the United States, about 13% of patients present with advanced melanoma (9% with regional disease and 4% with distant metastatic disease).
FACULTY:
LeAnn B. Norris, PharmD, FCCP, BCPS, BCOP, Clinical Associate Professor, University of South Carolina College of Pharmacy, Columbia, South Carolina
EDUCATIONAL OBJECTIVES:
At the completion of this activity, the participant will be able to:
- Identify the treatment options for patients with advanced melanoma
- Examine the latest clinical data for patients with advanced melanoma
- Explain the role of the pharmacist in supporting optimal treatment strategies in advanced melanoma management
TARGET AUDIENCE: Pharmacists
ACTIVITY TYPE: Application
RELEASE DATE: December 28, 2018
EXPIRATION DATE: January 12, 2020
ESTIMATED TIME TO COMPLETE ACTIVITY: 2.0 hours
FEE: This lesson is offered for free at www.pharmacytimes.org.
Articles in this issue
USP Ushers in Sweeping Changes to Rules for Hospital and Retail Pharmacies
What Are Treatment Approaches to Liver Cancer?
Baloxavir Marboxil Treats Acute Influenza in Otherwise Healthy Patients
What Are the Implications of the MERINO Trial?
Progress in Treating Advanced Melanoma: Pharmacists
Develop a Collaborative Pain Management Strategy
Are You the Gentamicin Pharmacist?
Related Content
